Renaissance Technologies (RenTech)'s NERV Position Overview
Renaissance Technologies (RenTech) (via Renaissance Technologies LLC) currently holds 73,300 shares of Minerva Neurosciences, Inc. (NERV) worth $406,815, representing 0.00% of the portfolio. First purchased in 2022-Q2, this medium-term investment has been held for 17 quarters.
Based on 13F filings, Renaissance Technologies (RenTech) has maintained a strategic position in NERV, demonstrating sustained confidence in this investment. Largest addition occurred in Q1 2024, adding 70,565 shares. Largest reduction occurred in Q1 2026, reducing 59,500 shares.
Analysis based on 13F filings available since 2013 Q2
Renaissance Technologies (RenTech)'s Minerva Neurosciences (NERV) Holding Value Over Time
Track share changes against reported price movement
Quarterly Minerva Neurosciences (NERV) Trades by Renaissance Technologies (RenTech)
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | -16,400 | Reduce 18.28% | 73,300 | $5.55 |
| Q1 2026 | -59,500 | Reduce 39.88% | 89,700 | $6.03 |
| Q4 2025 | +32,700 | Add 28.07% | 149,200 | $4.02 |
| Q3 2025 | +5,500 | Add 4.95% | 116,500 | $2.11 |
| Q2 2025 | -3,097 | Reduce 2.71% | 111,000 | $1.72 |
| Q1 2025 | -14,003 | Reduce 10.93% | 114,097 | $1.70 |
| Q4 2024 | -29,100 | Reduce 18.51% | 128,100 | $2.22 |
| Q3 2024 | -10,500 | Reduce 6.26% | 157,200 | $2.67 |
| Q2 2024 | -10,065 | Reduce 5.66% | 167,700 | $3.19 |
| Q1 2024 | +70,565 | Add 65.83% | 177,765 | $2.58 |
| Q4 2023 | +13,000 | Add 13.80% | 107,200 | $6.15 |
| Q3 2023 | -4,100 | Reduce 4.17% | 94,200 | $6.90 |
| Q2 2023 | -12,500 | Reduce 11.28% | 98,300 | $0.01 |
| Q1 2023 | +500 | Add 0.45% | 110,800 | $0.00 |
| Q4 2022 | +8,500 | Add 8.35% | 110,300 | $0.00 |
| Q3 2022 | +66,189 | Add 185.87% | 101,800 | $9.23 |
| Q2 2022 | +35,611 | New Buy | 35,611 | $3.31 |
Renaissance Technologies (RenTech)'s Minerva Neurosciences Investment FAQs
Renaissance Technologies (RenTech) first purchased Minerva Neurosciences, Inc. (NERV) in Q2 2022, acquiring 35,611 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies (RenTech) has held Minerva Neurosciences, Inc. (NERV) for 17 quarters since Q2 2022.
Renaissance Technologies (RenTech)'s largest addition to Minerva Neurosciences, Inc. (NERV) was in Q1 2024, adding 177,765 shares worth $459,000.
According to the latest 13F filing for Q2 2026, Renaissance Technologies (RenTech)'s firm, Renaissance Technologies LLC, owns 73,300 shares of Minerva Neurosciences, Inc. (NERV), valued at approximately $406,815.
As of the Q2 2026 filing, Minerva Neurosciences, Inc. (NERV) represents approximately 0.00% of Renaissance Technologies (RenTech)'s publicly disclosed stock portfolio, making it one of their key holdings.
Renaissance Technologies (RenTech)'s peak holding in Minerva Neurosciences, Inc. (NERV) was 177,765 shares, as reported at the end of Q1 2024.